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Section I: Abstract
Problem: The potential harm to women and infants due to untreated perinatal anxiety and mood
disorders is both a patient safety and a public health concern. Studies show that mental health
decline during the postpartum period is associated with increased morbidity and mortality for
both the mother and infant. The project aim was to utilize the initial screening of perinatal
patients using the Columbia-Suicide Severity Rating Scale (C-SSRS) as the baseline screening
tool. The tool will help implement a standardized workflow for patients who screen low,
moderate, or high, as this workflow had yet to be developed.
Context: In July 2019, the Joint Commission released new elements to their National Patient
Safety Goal 15.01.01: Reduce the risk for suicide, which required suicide screening for all
admitted patients. In August 2020, the hospital in this study screened all patients with the CSSRS on admission. Even when hospitals screen patients for suicide or other mental health
disturbances, a nationally accepted standard workflow for positive screens does not exist. This
improvement project focused on creating a standardized workflow for perinatal patients who
screened positive on the C-SSRS by implementing an inpatient clinical pathway.
Interventions: The primary intervention for this project was to create the inpatient clinical
pathway for perinatal patients who screen positive on the C-SSRS. The initial step in the
pathway was to ensure all positive patients had a social work consult, and those who scored
moderate or severe also had an inpatient psychiatry referral. The secondary intervention was to
ensure all patients received the Mind-Body-Spirit flyer containing outpatient resources for
continued support when they are home.
Measures: To measure the success of the C-SSRS pathway, the team tracked all perinatal
patients who screened positive on the C-SSRS. The outcome measure tracked the percentage of
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patients who screened positive on the C-SSRS and had the interventions completed. The first
process measure followed all positive C-SSRS patients against the number of social work
consults placed and seen before discharge. The second measure tracked all patients who screened
moderate or high, the psychiatry consult was initiated, and the patient was seen before discharge.
The third process measure was the percent of postpartum nurses trained to use the C-SSRS
clinical pathway. The incidence rate of inappropriate referrals to social work and psychiatry was
used as the balancing measure.
Results: Of the perinatal patients who screened positive (low, moderate, high) on the C-SSRS,
100% had a social work referral and were seen before discharge. Of the patients who screened
moderate or high, 100% had an inpatient psychiatry referral and were seen before discharge. The
safety plan was not initiated on the one patient who screened high, as she was in active labor and
the psychiatrist determined she was not actively suicidal. Education on the C-SSRS pathway was
successful, with 95% of postpartum nurses receiving the instruction.
Conclusions: This project aimed to develop an inpatient clinical pathway to be used with 90% of
perinatal patients who screened positive (low, moderate, high risk) on the C-SSRS. The hospital
in this study was able to implement the C-SSRS pathway on the postpartum unit successfully.
Keywords: Columbia-Suicide Severity Rating Scale (C-SSRS), perinatal mental health,
postpartum, screening tools
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Section II: Introduction
Over 600,000 infants are born in the United States every year to mothers who suffer from
perinatal depression (Postpartum Support International [PSI], 2021; Smith, 2012). Perinatal
mental health concerns are gaining attention at national, regional, and local levels. With the
added stress of the COVID-19 pandemic, mental health disparities have been recognized and
have shed light on this often-overlooked patient population. According to Choi et al. (2020),
Clinicians and experts are raising concerns about the pandemic’s potential to cause farreaching harm to the mental health of women and infants. During the pandemic, women
are at increased risk for depression, anxiety, post-traumatic stress disorder, and suicidality
precipitated by new pandemic-related stressors. (p. 410)
There are many missed opportunities to screen recently delivered mothers. When women
are not screened for mood disorders and left untreated, severe clinical depression may develop
for some women (Dennis & Doswell, 2013). In fact, “Perinatal mood and anxiety disorders are
associated with increased risks of maternal and infant mortality and morbidity and are
recognized as a significant patient safety issue” (Kendig et al., 2017, p. 272). Orsolini et al.
(2016) noted, “Perinatal suicidality, which comprises completed suicides, suicide attempts,
suicidal ideation, and thoughts of self-harm, is nowadays considered one of the leading causes of
maternal mortality in the first 12 months postpartum” (p. 2).
The Columbia-Suicide Severity Rating Scale (C-SSRS) is a validated screening tool used
to assess suicide risk (Columbia Lighthouse Project, 2016; see Appendix A). It is used by first
response agencies, healthcare facilities, military installations, colleges and schools, and
correctional facilities This risk assessment tool was created to be a simple, easy-to-read and
understand instrument using questions that anyone, including non-professional people, could use
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to determine if someone has suicidal thoughts. The C-SSRS is considered universal, as it has
been translated into over 100 languages and is suitable for use with any age group (Columbia
Lighthouse Project, 2016). Using the C-SSRS on admission could assist the healthcare team in
identifying at-risk perinatal patients, allowing for the implementation of patient-centered
interventions and resources.
Prior to the COVID-19 pandemic, the World Health Organization projected that by 2020,
depression would carry the highest disease burden of all health conditions in women (Dennis &
Doswell, 2013). It is also suspected that 50% of women with perinatal mood and anxiety
disorders (PMADs) are not identified (Accortt & Wong, 2017). When screening is implemented,
there is still a gap in coordinating and providing interventions (PSI, 2021). PMAD interventions
need to be created and inpatient clinical pathways solidified. Gaps in patient discharge planning
and resources have long been identified (Sullivan Group, 2021). Implementing patient and
family anticipatory teaching and resources should be standardized and dispersed to all applicable
patients and their support persons.
Problem Description
Most hospital systems in the United States have not routinely used validated tools to
screen pregnant and recently postpartum women (Long et al., 2019). When hospitals initiate
screening for depression, mood disorders, or suicidal ideation, there is a lack of patient-centered
interventions and resources. The hospital microsystem in this change in practice project
integrates the Patient Health Questionnaire (PHQ-9) screening tool in prenatal appointments and
routine pediatric appointments. Screening occurs at least twice during pregnancy and at wellbaby appointments. The American Congress of Obstetricians and Gynecologists recommends
screening with a validated tool for anxiety and depression symptoms at least once in pregnancy
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and postpartum (Accortt & Wong, 2017). The American Academy of Pediatrics recommends
screening mothers at every well-baby visit (Accortt & Wong, 2017). Even with double the
screening rate in this hospital, the postpartum microsystem still lacks an inpatient PMAD
pathway for perinatal patients.
In July 2019, the Joint Commission (2021) released new elements to their National
Patient Safety Goal (NPSG) 15.01.01: Reduce the risk for suicide, which required suicide
screening for all admitted patients. As a result of the revised NPSG, the hospital in this study
began screening patients with the C-SSRS in August 2020. From August 2020 through February
2021, data showed that 96% of patients were screened with the C-SSRS within 8 hours of
admission. The postpartum unit, also known as the mother-baby microsystem, did not have a
straightforward clinical pathway for positively screened patients.
In August 2019, the regional offices of the hospital system created a perinatal mental
health (PMH) group to improve the mental health of pregnant and newly postpartum patients and
formed a multi-professional and multi-medical center collaborative community of practice. The
initial goal was to formulate a patient-centered local resource list that would be provided during
discharge teaching. In July 2021, the revision of an established regional patient handout, titled
the Mind-Body-Sprit flyer, was completed as one of the interventions implemented during the
project (see Appendix B). The initial regional patient handout had some inaccurate phone
numbers and was missing other local resources; thus, the team needed to revise before initial
distribution. Once finalized, the flyer required a way for distribution, so that all patients would
receive it and be educated on the contents.
Growing the local PMH team and using the interdisciplinary members for improvement
projects was one way to improve communication and unite the team. The original project aim
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was to decrease untreated PMAD symptoms in the patient, the newborn baby, and the entire
family unit. After a gap analysis, it was found that before working on PMAD interventions, there
was a need to improve upon a pre-established C-SSRS clinical pathway to identify those at risk
of self-harm, establish a treatment algorithm, and ensure patients are provided support and
resources.
Available Knowledge
PICOT Question
In postpartum women (P), how does using a screening tool to identify at-risk moms for
postpartum mental disturbances (I), compared to those without the use of a screening tool (C),
affect mood or psychiatric disturbance identification and treatment (O) within one year
postpartum (T).
Multiple literature reviews were conducted throughout the planning and implementation
phase of the project. Topics searched included screening and implementing interventions for
perinatal mood disorders. The initial literature review conducted in February 2020 was followed
up with ongoing research completed in July 2021. The evidence was reviewed using the
following databases: Cochrane Database of Systematic Reviews, CINAHL Complete, Pub Med,
MEDLINE, and AHRQ evidence reports. Keywords searched included postpartum, mental
illness, psychiatric disorders, mood disorders, reducing maternal symptoms, and screening tools.
Limitations were set to include English language, peer-reviewed research, and publication dates
of 2015 to 2021. The Cochrane review was published in 2013 and was included due to the
thoroughness of the study. Ten articles were retrieved with clinical significance to the PICOT
question, and eight were selected for review.
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Literature Review
The Johns Hopkins Nursing Evidence-Based Practice research and non-research evidence
appraisal tools were selected to review the evidence (Dang & Dearholt, 2018). Three Level I A
articles, one Level II B, one Level III B, one Level IV B, one Level V A, and one Level V B
were selected to broaden the understanding of the problem and included in the evidence-based
research table (see Appendix C).
The Cochrane review (Level I A) included 28 randomized controlled trials using both
primary meta-analysis and fixed-effect meta-analysis to combine the study data with a sample
size of 17,000 pregnant or newly postpartum women (Dennis & Doswell, 2013). This study
showed that women who received a psychosocial or psychological intervention were
significantly less likely to develop postpartum depression than those receiving standard care,
with an average RR 0.78 and 95% confidence interval. The top three identified interventions
were individualized postpartum home visits, peer-based telephone support, and interpersonal
psychotherapy (Dennis & Doswell, 2013).
The next Level I A study by Long et al. (2019) included 25 systematic reviews and metaanalysis studies. This study revealed that screening for perinatal mood disorders is inconsistent
and low among healthcare providers in the United States. Long et al. indicated that not only does
screening need to be implemented, but referrals are needed as well.
Song et al. (2015) looked at 14 randomized control trials in a systematic review, and 13
of those studies were included in a meta-analysis (Level I A). Their results showed that the use
of psychosocial interventions, such as stress management, proved to be an effective treatment for
reducing symptoms of depression.
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McCarter-Spaulding and Shea (2015) completed a quasi-experimental study including
240 women (rating Level II B), showing that educating women about postpartum depression
symptoms while in the hospital did not decrease their symptoms.
Albaugh et al. (2018), in a retrospective descriptive study of 647 women (Level III B),
provided information that only half of the women referred for mental health during their
postpartum period attended their appointment.
Choi et al. (2020) provided practice guidelines and recommendations (Level IV B),
pulling information from 17 organizations to address the COVID-19 pandemic and increasing
concerns for mental health disturbances to rise.
A literature review by Accortt and Wong (2017) revealed that 19.2% of postpartum
women experience depressive symptoms in the first 3 months postpartum (Level V B); therefore,
routine screening with validated tools is necessary. They also identified that depression and
anxiety rates are higher for women who experience an adverse perinatal complication or
outcome, such as a baby in the neonatal intensive care unit (NICU), preterm birth, or maternal
preeclampsia.
The final article chosen for review was a literature review and practice standards,
including four studies (Level V B). Potter (2017) looked at universal screening for mood
disorders for childbearing women and implications for practice. The researcher noted, “Ensuring
universal screening and accurate diagnosis is just the first step; culturally competent,
comprehensive, and effective treatment options must be available to all women” (Potter, 2017, p.
459).
Synthesizing the evidence revealed that the foundational perinatal mental health problem
lacks consistent screening for mood disorders in this patient population. Even though many
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organizations have established clinical guidelines, not all healthcare systems consistently use
validated screening tools during the perinatal periods. After reviewing the PICOT question and
evidence, it was determined that the hospital and microsystem in this improvement project was
already consistently using these validated tools. Initially, the project focused on creating an
inpatient PMAD clinical pathway with referrals, treatment options, and easily accessible
resources. The PMAD pathway was too broad, so the PMH team decided to begin by creating the
C-SSRS clinical pathway (see Appendix D). Those patients with self-harm thoughts are a
smaller, more targeted group. Research has shown that the prevalence of suicidal ideation during
the perinatal period ranges from 5% to 14% (Orsolini et al., 2016). Starting with a smaller patient
population gave the team a tangible improvement project.
Rationale
Neuman (2017) systems model and McGonigal’s (2017) 4C change model constituted the
project’s conceptual and systems model frameworks. Partnered together, the two models helped
guide the evidenced-based practice change of initiating a clinical pathway for interventions and
resources for at-risk moms.
Neuman (2017) systems model is a unique, open, systems-based perspective that focuses
on wellness and the person as a whole and guides the nurse to see their client (the preferred term)
in a holistic view. The sole purpose is not just for the individual, but also for groups,
communities, organizations, and families. Betty Neuman developed her systems model in 1970
as a conceptual framework to help guide her students’ learning at the University of California
Los Angeles. Since 1970, the Neuman systems model has continued to evolve and has become
one of the top conceptual models used by nursing. Neuman’s model “focuses attention on the
response of the client system to actual or potential environmental stressors, and the use of
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primary, secondary, and tertiary nursing prevention interventions for retention, attainment, and
maintenance of optimal client system wellness” (Neuman, 1996, p. 67). This resiliency
encompasses physiological, psychological, sociocultural, developmental, and spiritual variables
simultaneously, where optimal health encompasses total health attainable at one moment in time
(Neuman, 2017).
Kotter’s well-respected change model was used as the foundation of the 4C model
(McGonigal, 2017). This model can be the framework to tackle any evidence-based
improvement project, from simple to complex. The first step in the model is to center, or create a
clear focus, on the issue at hand. The second step is collaboration, or bringing the team together
using straightforward communication tools. The third step of change uses tools, such as plan-dostudy-act (PDSA), to make the change. The fourth and final step is to celebrate success. This
model has been successful in other change initiatives in the postpartum unit of focus.
Specific Project Aim
This project aims to develop an inpatient clinical pathway to be used with 90% of
perinatal patients who screen positive (low, moderate, high risk) on the C-SSRS by July 2021.
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Section III: Methods
Context
The focus of the population is from the postpartum unit in a large medical center in
Northern California with 60 licensed postpartum beds and an average monthly delivery volume
of 550 babies. The Institute for Healthcare Improvement’s (IHI) microsystem assessment tool
and the Dartmouth Institute’s microsystem assessment tool (IHI, 2003) were used to assess this
microsystem in February 2021. The multidisciplinary team includes a nurse manager, 12
assistant nurse managers, 200 obstetrical doctors and midwives, six pediatricians, five licensed
clinical social workers, and 130 staff nurses. The assessment identified that multidisciplinary
work was needed surrounding perinatal mental health.
The hospital unit had good foundational work, beginning with screening using the CSSRS with every admission since August 2020 (Columbia Lighthouse Project, 2016). In addition
to the C-SSRS, abuse, AUDIT (alcohol use disorders identification test), mutuality/individual
preferences, and mental health review of symptoms questions are all asked upon admission to
labor and delivery. These tools are all validated for screening purposes, but no guidelines were in
place for follow-up when patients screen positive.
SWOT Analysis
The PMH team conducted a SWOT (strengths, weaknesses, opportunities, and threats)
analysis, showing that the strengths of this work outweigh the threats (see Appendix E). The
project’s strengths were that the C-SSRS screening was a standard of practice, and social work
referrals were already being placed for many patients with PMAD symptoms. Other potential
strengths of the project were increasing communication and awareness of PMAD symptoms and
improving patient outcomes. The potential weaknesses included staff resistance to change and
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patients not being ready for intervention. Other potential weaknesses and threats could involve
the impact on outpatient resources, with delays in outpatient appointments due to availability.
Opportunities for this project could consist of spreading discovered best practices to other
postpartum units, decreasing the stigma of PMAD, and identifying individuals with thoughts of
self-harm. Early identification and intervention lead to better patient outcomes.
Cost-Benefit Analysis
The PMH team also completed a cost/benefit analysis (see Appendix F). The preliminary
budget for the startup and continuation of the C-SSRS pathway is associated with employee
salary and printing the Mind-Body-Spirit flyer. Utilizing established staff would mitigate any
cost increase. Using an established 5-minute huddle message at the start of the shift by the
assistant nurse manager and during the monthly staff meetings was the education method used.
Nominal costs associated with the general use of resources could also be captured in the routine
unit budget. The only additional procurement of resources necessary for the C-SSRS clinical
pathway to succeed is printing the Mind-Body-Spirit flyer. The annual cost for this flyer at this
medical center is $1,553.64. Patients placed on the C-SSRS clinical pathway could decrease
long-term outpatient budgets. A report published by Mathematica estimated that untreated
perinatal mental health disorders cost the United States $14.2 billion in 2017 (PSI, 2021).
Decreasing the risk of a mood disorder from turning into severe clinical depression and
then self-harm could reduce outpatient and later inpatient mental health needs. According to
Accortt and Wong (2017), “Depression increases health care costs and decreases productivity of
women affected, as well as the well-being of their offspring” (p. 559).
Intervention
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Focused interventions facilitate decreasing the adverse effects that PMADs can have on a
patient and their family. These interventions begin upon admission by screening all patients with
the C-SSRS. The primary intervention is triggering the social work and psychiatry consults,
when indicated. Secondary preventative approaches, such as social support, stress reduction
techniques, psychological therapies, cognitive behavioral therapy, or when indicated,
pharmacological treatments (Accortt & Wong, 2017), will be added in later. The final
intervention is educating all postpartum nurses on using the new pathway.
Study of the Intervention
Measurement is key to the implementation success of any quality improvement project.
The PMH team used several PDSA cycles looking for the best interventions for their
microsystem. Evaluation of the C-SSRS pathway occurred daily with internal audits of Health
Connect, the secure communication network, or the inpatient record. The auditor used the
Suicide Risk Harvey Ball on the patient list to quickly assess all perinatal patient charts to
determine if they had been screened with the C-SSRS tool on admission. Next, the auditor
verified that those who screened positive had a social work referral and those who screened
moderate or high also had a psychiatry referral. There was planned auditing for distribution of
the Mind-Body-Spirit resource handout; however, the revised handout was not available until
after the initial project implementation. According to McCarter-Spaulding and Shea (2015),
“Limited nursing time during hospitalization may be better spent on implementing a mechanism
for ensuring adequate follow-up after discharge for women at risk” (p. s59); therefore, future
PDSA cycles will revolve around utilizing resources after discharge.
When the inpatient C-SSRS clinical pathway was created, many PDSA cycles were
performed to help determine the next steps. The Mind-Body-Spirit resource list was updated by
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the PMH team, and after the implementation period, the team trialed ways to make the
distribution meaningful. These were rapid-fire cycles based on the nurses’ verbal input. Initially,
they trialed having the flyer handed to the patient on admission; next, they trialed giving it to the
patient with the discharge instructions. The preliminary results showed that for sustainability, the
flyer should be placed in the admission packet, so that the admission and discharge nurses could
go over it with the patient and support persons. Having the flyer at the bedside on admission
made it easy for the nurse to pull it out and share it with the patient. Expecting that both the
admission and discharge nurse would go over the flyer increased the discussion rate and ensured
distribution to 100% of patients.
The group also conducted two PDSA cycles on downloading and using the Calm
application (app) with patients (see Appendix G). In the first 2-week trial, the selected
postpartum nurses assisted their patients with downloading the Calm app. The second 1-week
trial included asking the patient to use the app at least once during their hospitalization. The
Calm app is a stress management/relaxation tool that could assist in reducing symptoms of
depression. This app was vetted by the hospital system and is offered free for a year to members.
The Calm app PDSAs are still in progress, with favorable preliminary results. The Calm app
PDSA cycles had to be temporarily put on hold during the implementation period, as the free
link was temporarily disabled. The link was enabled after a short time, and the team has plans to
continue working on PDSAs using it.
Future PDSA cycles will involve the discharge nurse assisting the patient in signing up
for a class or support group before discharge. The group looked at other PMAD interventions,
such as instituting talking therapy utilizing the primary nurse or obstetric rounder to ask the
patient how their delivery went, and then listen to their perspective of the delivery experience. If
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the conversation raised concerns that the patient had unresolved questions about the birth, they
would call the nurse midwife (or another provider) and ask for a debrief. As this was subjective
data, the group decided to hold off on the talk therapy and debrief PDSAs until after completing
the C-SSRS project. In addition, the PMH team determined that the PDSA cycle of discharge
calls, asking the patient about the Calm app and the Mind-Body-Spirit flyer, was currently
unsustainable.
Measures
Four measures were created to assess the proper implementation of the C-SSRS pathway:
three process measures, an outcome measure, and a balancing measure. An initial project charter
was created in February 2021 surrounding perinatal mental health needs (see Appendix H) and
was later updated to the narrower focus of the C-SSRS implementation. The outcome measure
included the successful implementation of the C-SSRS pathway. To be considered successful,
the team had to ensure that 90% of patients who screen positive (low, moderate, high risk) on the
C-SSRS would have a social work referral placed, and 100% of those patients who screen
moderate or high would have an inpatient psychiatry order placed and a safety plan initiated
when high.
The first process measure was a social work referral triggered upon admission by a
perinatal patient who screened low, moderate, or high on the C-SSRS. The future goal of the
complete PMAD pathway will also include patients who screen positive on the abuse, AUDIT,
mental health review of symptoms, and the outpatient PHQ-9 score of 10 or higher and patients
with a traumatic delivery requiring a debrief, NICU admission, or fetal demise. The second
process measure tracked all patients who screened moderate or high on the C-SSRS and had
inpatient psychiatry referrals and visits before discharge. The third process measure was the
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percent of postpartum nurses trained to initiate the C-SSRS clinical pathway, with a goal of 90%
of nurses educated. The balancing measure was the incidence rate of inappropriate referrals to
inpatient social work and psychiatry. The goal was not to miss any at-risk patients while using
the resources already available.
Ethical Considerations
Enhancing maternal mental health is fundamental for decreasing clinical depression, thus
reducing the burden of disease. According to Dennis and Doswell (2013), “There is a substantial
body of evidence showing that maternal depression and subsequent poor maternal-infant
interactions adversely affect the developing child” (p. 4). A project focused on improved mental
health for perinatal patients and improved maternal and child health is ethically sound. The CSSRS pathway will increase the postpartum nurses’ knowledge, skill, and attitudes surrounding
perinatal mental health. Decreasing PMAD stigma will engage the frontline nurses and increase
their job satisfaction.
This project aligns with the American Nurses Association’s (ANA) nine provisions of the
Code of Ethics for Nurses. Provision 1 states, “The nurse practices with compassion and respect
for the inherent dignity, worth, and unique attributes of every person” (ANA, 2015, para. 1).
Provision 3 states, “The nurse promotes, advocates for, and protects the rights, health, and safety
of the patient” (ANA, 2015, para. 3). Creating a safe environment for the patient, including
identifying one’s suicide risk and other PMAD indicators, follows these provisions.
After review from the University of San Francisco faculty, this project was determined to
qualify as an evidence-based change in practice project rather than a research project. When a
project is a change in practice and not research, Institutional Review Board approval is not
required. A statement of determination as a non-research project was approved (see Appendix I).
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Section IV: Results
Outcome Measure Results
Preliminary data revealed that the PMH team was successful in the implementation of the
C-SSRS pathway. Prior to implementation, only 50% of patients with a positive screen (low,
moderate, high) on the C-SSRS had the correct interventions of social work and/or psychiatry
referrals placed and seen before discharge. After implementation, 100% of patients who screened
moderate and high had an inpatient social work and psychiatry order placed and were seen
before discharge (see Appendix J). One patient screened high post-implementation, but was in
active labor and cleared by the psychiatrist, so the additional safety plan was not initiated. There
were no patients who scored low on the C-SSRS during the implementation period of June and
July 2021. Ninety-five percent of postpartum nurses, subtracting those on a medical leave during
implementation, were educated on the C-SSRS pathway during the huddle message and staff
meetings.
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Section V: Discussion
Summary
The PMH team successfully implemented the C-SSRS clinical pathway in June of 2021
on the postpartum unit. There were many lessons learned during the implementation period. The
first lesson learned was that it is crucial to break down a project into smaller, more tangible
pieces when initiating a change of such breadth. The evidence revealed that the hospital was
already screening 96% of their patients with the C-SSRS, but needed improvement with
referrals, treatment options, and resources. This improved workflow proved to be the foundation
required before moving other perinatal mood disorder work forward.
Pulling together a multidisciplinary team to form a PMH group proved to be the first
challenge encountered. With implementing a change in practice in such a busy postpartum
department, there are many competing priorities. Key stakeholders needed to be included and
kept informed of the work. Before the project initiation, there were no providers who wanted to
head up the PMH group. The clinical nurse leader student was already an established leader on
the unit as an assistant nurse manager for over 10 years. Using her influence, experience, and
knowledge of the providers’ passions, she secured an OB/GYN physician and a certified nurse
midwife for the team. Still, completing this group did take more time than anticipated. Once the
group formed, there was buy-in from like-minded, passionate individuals. Even when not all
team members could attend the meetings, email and one-on-one interactions moved the work
forward.
Conclusion
The decline in perinatal mental health acute and long-term effects is an urgent public
health issue in the United States (PSI, 2021). All postpartum microsystems could benefit from
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streamlining the inpatient pathway for PMADs, beginning with screening using the C-SSRS, to
improve the mental health of this patient population. Kendig et al. (2017) reported,
When left untreated, perinatal mood and anxiety disorders can have profound adverse
effects on women and their children, ranging from increased risk of poor adherence to
medical care, exacerbation of medical conditions, loss of interpersonal and financial
resources, smoking and substance use, suicide, and infanticide. Perinatal mood and
anxiety disorders are associated with increased maternal and infant mortality and
morbidity risks and are recognized as a significant patient safety issue. (p. 272)
Patient safety concerning mortality and morbidity is one implication for sustained
practice improvement. In 2020, the hospital system in focus put out a Health Stream, an online
educational training module, educating all frontline nursing staff on the new NPSG to reduce the
risk for suicide and the corresponding implementation of the C-SSRS as their screening mode.
Even with this education, many labor and delivery and postpartum staff members did not see this
goal as a priority for their patient population. With a lengthy module not tailored to their needs,
and due to the added stress of the COVID-19 pandemic, it did not get initiated in a viable way in
2020.
Improving PMAD and C-SSRS screening and using easy-to-follow inpatient clinical
pathways that include referrals, treatment options, and easily accessible outpatient resources for
discharge are simple ways to help this vulnerable population. When you make simple workflow
changes easy to follow, they have built-in sustainability. Decreasing the risk of exacerbating
PMAD symptoms, such as self-harm, by supporting families through early screening, treatment
and resources supports and builds a healthy family dynamic.
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Appendix A. Columbia-Suicide Severity Rating Scale
Please place a check mark in the box for the appropriate answers
Please answer question 1 and 2
Ask Questions 1 and 2
1) Have you wished you were dead or wished you could go to sleep and not

wake up?

2) Have you actually had any thoughts of killing yourself?
If YES to 2, ask questions 3, 4, 5, and 6. If NO to 2, go directly to question 6.
3) Have you been thinking about how you might do this?
e.g. “I thought about taking an overdose but I never made a specific plan as to

when where or how I would actually do it….and I would never go through with it. ”
4) Have you had these thoughts and had some intention of acting on them?
as opposed to “I have the thoughts but I definitely will not do anything about
them.”
5) Have you started to work out or worked out the details of how to kill

yourself? Do you intend to carry out this plan?

6) Have you ever done anything, started to do anything, or prepared to do

anything to end your life?

Examples: Collected pills, obtained a gun, gave away valuables, wrote a will or suicide note,
took out pills but didn’t swallow any, held a gun but changed your mind or it was grabbed
from your hand, went to the roof but didn’t jump; or actually took pills, tried to shoot
yourself, cut yourself, tried to hang yourself, etc.
If YES, ask: Was this within the past 3 months?
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Appendix B. Mind-Body-Spirit Flyer
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Appendix C. Evaluation Table
PICOT Question: In postpartum women (P), how does using a screening tool to identify at-risk moms for postpartum mental
disturbances (I), compared to those without the use of a screening tool (C), affect mood or psychiatric disturbance identification and
treatment (O) within 1 year postpartum (T).
Study

Design

Sample

Accortt, E. E., & Wong, M. S. (2017).
Literature review
It is time for routine screening for
perinatal mood and anxiety disorders in
obstetrics and gynecology settings.
Obstetrical and Gynecological Survey,
72(9), 553–568.
https://doi.org/10.1097/ogx.000000000
0000477

4,700 patients

Albaugh, A. S., Friedman, S. H., &
Rosenthal, M. (2018). Attendance at
mental health appointments by women
who were referred during pregnancy or
the postpartum period. Journal of
Obstetric, Gynecologic & Neonatal
Nursing, 47(1), 3–11.
https://doi.org/10.1016/j.jogn.2017.11.
001

647 women

Retrospective
descriptive study

Outcome/Feasibility
Data revealed that 19.2% of
postpartum women experience
depressive symptoms in the first 3
months postpartum.

Evidence
Rating
VA

Helpful in providing the 9 PHQ as
a tool for assessment before
discharge (after delivery).
Only half of the women referred
for mental health during their
postpartum period attended.
Helpful knowledge for CNL for
follow-up evaluation.

III B
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Study

Design

Sample

Outcome/Feasibility

Choi, K. R., Records, K., Low, L. K.,
Practice
Alhusen, J. L., Kenner, C., Bloch, J. R., guidelines and
Premji, S. S., Hannan, J., Anderson, C. recommendations
M., Yeo, S., & Logsdon, M. C. (2020).
Promotion of maternal-infant mental
health and trauma-informed care
during the COVID-19 pandemic.
Journal of Obstetric, Gynecologic &
Neonatal Nursing, 49(5), 409–415.
https://doi.org/10.1016/j.jogn.2020.07.
004

17
organizations

Dennis, C. L., & Doswell, T. (2013,
February 28). Psychosocial and
psychological interventions for
preventing postpartum depression.
Cochrane Database of Systemic
Reviews.
https://doi.org/10.1002/14651858.CD0
01134.pub3/full

17,000 women
in 28
randomized
controlled
trials

Early identification of at-risk
mothers contributed to decreased
levels of postpartum depression.

25 studies

A review of the studies indicates
that the use of a screening and
referral system is needed.

Retrospective
analysis and
primary metaanalysis and
fixed-effect metaanalysis

Long, M. M., Cramer, R. J., Jenkins, J., Systematic
Bennington, L., & Paulson, J. F.
reviews and meta(2019). A systemic review of
analysis
interventions for healthcare
professionals to improve screening and
referral for perinatal mood and anxiety
disorders. Archives of Women’s Mental
Health, 22(1), 25–36.
https://doi.org/10.1007/s00737-0180876-4

Guidelines for maternal health
during a pandemic, covering
inpatient postpartum
considerations.

Evidence
Rating
IV B

Useful for current pandemic
situation (raising concerns for
increased risk for mental health
disturbances).

IA

Guides the CNL in proposing
interventions, including resources.

It guides the CNL to propose a
consistent screening tool for
perinatal mood and anxiety
disorders (PMAD) in their
microsystem.

IA
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Study

Design

Sample

McCarter-Spaulding, D., & Shea, S.
(2015). Effectiveness of postpartum
education in the reducing symptoms of
postpartum depression. Journal of
Obstetric, Gynecologic & Neonatal
Nursing, 44(1), S58–S59.
https://doi.org/10.1111/15526909.12629

Quasiexperimental

240 women

Potter, M. T. (2017). Nurse-led
initiatives to implement universal
screening for perinatal emotional
complications. Nursing for Women’s
Health, 21(6), 452–461.
https://doi.org/10.1016/j.nwh.2017.10.
010

Literature review
and practice
standards

4 studies

Outcome/Feasibility
Educating postpartum moms on
depression symptoms while in the
hospital did not decrease
symptoms of postpartum
depression.

Evidence
Rating
II B

The CNL can use the
recommendation of spending time
implementing a pathway for
follow-up for at-risk moms after
discharge instead of educating
moms inpatient.
The use of the Edinburgh Postnatal V B
Depression Scale (EPDS) is the
most common and reliable tool.
The CNL looks at professional
practice standards and utilizes
AWHONN, ACOG, and American
College of Nurse-Midwives
position statements for screening
to implement use.
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Study
Song, J.-E., Kim, T., & Ahn, J.-A.
(2015). A systematic review of
psychosocial interventions for women
with postpartum stress. Journal of
Obstetric, Gynecologic & Neonatal
Nursing, 44(2), 183–192.
https://doi.org/10.1111/15526909.12541

Design

Sample

Outcome/Feasibility

Randomized
controlled trials,
systematic review,
and meta-analysis

14 RCTs in the
systematic
review, 13
studied
included in a
meta-analysis

The use of psychosocial
interventions (including stress
management) proved to be
effective in reducing symptoms of
depression.
The CNL should include
psychosocial programs in the
postpartum plan of care.

Evidence
Rating
1A
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Appendix D. Columbia-Suicide Severity Rating Scale (C-SSRS) Clinical Pathway
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Appendix E. SWOT Analysis
SWOT Analysis

Strengths
•C-SSRS screening established
•SW already active team
members
•Increases communication
about mental health
•Early indentification could
decrease symptoms of PMAD
•Improves patient outcomes

Weaknesses
•Staff could resist change
•Some patients might not be
ready for interventions
•Potential delay in patient
being seen by inpatient psych
•Might not have outpatient
services available within
resonable time frame

Threats

Opportunities

•Nurses perceived as acting
outside of their scope of
practice
•Finding more patients needing
interventions without enough
outpatient resources

•Can be spread to other units
•Small size might aid change
adaption
•Decreasing stigma of PMAD
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Appendix F. Cost-Benefit Analysis
FTE Expense
160 staff, 5-minute education during the beginning of shift huddle and staff meetings. Clinical
nurse leader (CNL) student time for the project. PMH team meetings included $86 per hour per
RN. Other team members are exempt and work the meeting into their regularly scheduled shift.
Non-FTE Expense
Mind-Body-Spirit flyer $11.77 per pack of 50
For 550 (average delivery per month) cost is $129.47 per month or $1,553.64 per year
The total cost for the first year with FTE and Non-FTE expenses is $4,913.64
FTE Expense

Startup

Annual Cost

Total Cost First Year

Education during staff
meeting
Education during huddle

$0

$0

$0

$0

CNL student time

$0

$0

$0 (already in annual
budget)
$0 (already in annual
budget)
$0

Committee meeting time:
$86/hour per RN

3 RNs x 6 startup
meetings =
$1,548

3 RNs x 12
(monthly meetings)
= $3,096.

$4,644

Non-FTE Expense

Startup

Annual Cost

Total Cost First Year

Mind-Body-Spirit Flyer

$129.47/month

$1,553.64

$1,553.64

Calm app

$0 - free to KP
members for the
first year

$0 for the first year

The annual cost for
the patient after the
first year is $69.99
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Appendix G. Calm App PDSA

Calm App Job Aid
Step 1: Scan barcode with camera

STEP 2: Scroll down until you see the “Get Calm” button and click on it

Step 3: Log into KP.org

STEP 4: Download Calm app by selecting “Get”

Step 5: Enjoy app free for 1 year
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Appendix H. Project Charter
Perinatal Columbia-Suicide Severity Rating Scale (C-SSRS) Clinical Pathway Charter
Project Charter: Inpatient Perinatal C-SSRS clinical pathway project charter.
Global Aim: To decrease symptoms of perinatal mood and anxiety disorders (PMAD) and
increase women’s mental health, thus decreasing potential adverse effects on newborn babies
and families.
Specific Aim: The aim of this project is to develop an inpatient clinical pathway to be used with
90% of perinatal patients who screen positive (low, moderate, high risk) on the ColumbiaSuicide Severity Rating Scale (C-SSRS) by July of 2021.
Background:
Mental health, in particular perinatal mental health, is gaining attention, as the World Health
Organization projected that by 2020, depression would carry the highest disease burden of all
health conditions in women (Dennis & Doswell, 2013). There are many missed opportunities to
screen inpatient perinatal patients. When patients are not screened for mood disorders or are
screened and not treated, severe clinical depression can occur for some women (Dennis &
Doswell, 2013). Accortt and Wong (2017) reported that “PPD (postpartum depression) is the
most common complication associated with pregnancy and childbirth” (p. 554). It is also
suspected, by self-reports, that 50% of persons with perinatal mood and anxiety disorders are not
identified (Accortt & Wong, 2017). Even when screening is implemented, a gap can occur with
identifying interventions during hospitalization and creating pathways for patients (Potter, 2017).
These interventions would need to be made, and pathways solidified. Resources for discharge
need to be identified, consolidated in a way that is easy to understand, and then shared with
patients.
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At-risk postpartum patients are those with PMAD, birth trauma, NICU admission,
posttraumatic stress disorder, and socioeconomic risk factors. Many hospital systems in the
United States do not consistently use the available validated tools to screen pregnant and recently
postpartum women, even though the American College of Obstetricians and Gynecologists
(ACOG) and other public health organizations have widely recommended it (Accortt & Wong,
2017). Even when hospitals initiate screening for depression or other mood disorders, there is
still a lack of interventions and resources. The hospital that is the focus of this study integrates
the Patient Health Questionnaire (PHQ-9) screening tool in prenatal appointments and routine
newborn, pediatric appointments. While the screening rate is high, there is no standard of
practice or clinical pathway for inpatient perinatal patients.
Sponsors
Chief Nurse Executive

DR

Director of Women’s and Children’s

MB

Chief of Obstetrics and Gynecology
(OBGYN and CNM Chiefs)

JC & MB

Goals
The purpose of this project is to decrease perinatal mood disorders from adversely affecting
women and babies by:
1. Using current screening tools to identify at-risk patients consistently.
2. Creating and implementing a clinical pathway for nurses and providers to follow when a
postpartum woman is identified as at-risk for perinatal mood disorders, beginning with
the Columbia-Suicide Severity Rating Score.
3. Educating all staff on the new pathway.
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Measures
Measure
Outcome

Data Source

Target

C-SSRS workflow utilization
Process
Social work (SW) referral for
low/moderate/high C-SSRS
Psychiatry referral for
moderate and high C-SSRS
Percent of postpartum nurses
trained to use C-SSRS
workflow
Balancing
The incident rate of
inappropriate referrals to
inpatient SW and psychiatry
MD

Chart review - Health Connect

90%

SW referral inbox in Health
Connect
Psychiatry note in Health
Connect
Huddle message and staff
meeting attendance

90%

Health Connect

<10% increase from
baseline

100%
90%

Team
Project Lead

KS

MD and CNM Leads

KN & LW-N

Social Work Lead

MD

RN Champions

JK, TG, KW, DF-G & SC

Director of Women’s and Children’s

MB

MD Consultants

Dr. M, Dr. B, Dr. F

Maternity Services Clinical Nurse Leader

HC

Quality Nurse Consultant

RP

Measurement Strategy
Background (Global Aim): To decrease symptoms of perinatal mood disorders and increase
women’s mental health, thus decreasing potential adverse effects on newborn babies and
families.

41
Population Criteria: Inpatient perinatal patients who screen mild, moderate, or high on the CSSRS when admitted to the hospital.
Data Collection Method: Data will be obtained daily from the hospital obstetrical census in
Health Connect and a report generated from the regional database.
Data Definitions
Data Element
PHQ-9

C-SSRS

RN training
Social work referrals

Definition
Patient Health Questionnaire is the depression module of the DSMIV (American Psychiatric Association for the classification of
mental disorders).
Columbia-Suicide Severity Rating Scale. Suicide risk: low risk
(score 1-2, no immediate concern or intervention required),
moderate risk (score 3, intervention needed), or high risk (score 46, intervention required).
Education for all labor and delivery and postpartum nurses on the
C-SSRS workflow.
Referrals to social work through the inbox in Health Connect.

Measure Descriptions
Measure
Percent of social
work (SW) referrals
for positive C-SSRS
screening

Measure Definition
N = # of patients with
SW referral (positive on
C-SSRS)
D = # of patients who
screened positive on CSSRS
Percent of psychiatry N = # of psychiatry
referrals for moderate referrals
or high C-SSRS
D = # of moderate and
screening
high C-SSRS patients
Percent of RNs
N = # of postpartum
trained on C-SSRS
(PP) nurses trained on
workflow
the C-SSRS workflow
D = # of total PP nurses
Key: N = numerator, D = denominator

Data Collection Source
Health Connect

Goal
90%

Health Connect

90%

Huddle and staff meeting
attendance (sign off sheet)

90%
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Driver Diagram
Aim

Primary Driver

Secondary Driver

SW education
% of patients referred
to SW for positive
screen on C-SSRS

Change Ideas

Incorporate SW
referrals into C-SSRS
workflow

RN education/screening
patients

Increase utilization
of the new CSSRS workflow
from 0% to 90%
by the end of July
2021
Education and training
of all L&D and PP RN's
on C-SSRS workflow

RN's initiate SW
referrals and follow CSSRS workflow
Mandatory Education
RN's educate the
patients's on the MindBody-Spirit resource
flyer
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Changes to test
1. When patients screen low, moderate, or high on C-SSRS have established workflow.
2. When patients are admitted with a prenatal diagnosis of a PMAD, have an established
workflow.
3. When a baby goes to the NICU, have an established workflow.
4. MB RN helps patients download the Calm app for all at-risk patients.
5. Give all patients the Mind-Body-Spirit flyer before discharge.
6. Use a team engagement plan with a kickoff for morale and motivation.

Admitted postpartum patient

L&D RN conducts C-SSRS and
puts in a SW referal for
patients who score low,
moderate, or high

C-SSRS workflow initiated

L&D RN, Provider, or MB RN
put in referal to SW for every
patient with a prenatal
diagnosis of a PMAD

PMAD workflow initiated
(yet to be established)

L&D RN or MB RN put in SW
referal for every parent who's
baby gets admitted to the
NICU

PMAD workflow initiated
(yet to be established)
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Project timeline
Implementation 2/2021
Step
Define the
project
Develop the
AIM
Review
literature
Microsystem
assessment
Develop
charter
Create
measurement,
outcomes,
processes, and
balancing
Identify team
and kickoff
meeting
Identify
changes to test
Driver diagram
Complete
charter
Test changes
Train staff on
workflows
Evaluation &
ongoing
performance
improvement

3/2021

4/2021

5/2021

6/2021

7/2021

Ongoing
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CNL Competencies
Clinical Nurse Leaders (CNLs) are “positioned in the microsystem and serve as leaders
of teams who often identify process or system concerns and then work with interdisciplinary
colleagues to implement evidence-based interventions to achieve improvement” (Harris et al.,
2018, p. 313). While working in their microsystem, they embody several of the CNL
competencies enacted by the American Association of Colleges of Nursing (AACN, 2007) in
their white paper.
Many competencies will be leveraged to implement a pathway for intervention and
resources for at-risk inpatient perinatal women. The CNL will act as an educator and team
leader, helping to coordinate and collaborate with the entire microsystem. The CNL works as an
outcomes manager by looking at the processes to drive ideal results (King et al., 2019). As a
systems analyst, the CNL is positioned to utilize and evaluate quality measures in their
microsystem (King et al., 2019). With this scope of practice, the CNL will make evidence-based
changes in their microsystem.
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Appendix I. Statement of Non-Research Determination

CNL Project: Statement of Non-Research Determination Form
Student Name:___Kristin Schoen___________
Title of Project:
Columbia-Suicide Severity Rating Scale (C-SSRS) Inpatient Perinatal Clinical Pathway
Brief Description of Project:
Creating a clinical pathway for patients who screen positive (low, moderate, high risk) on
the C-SSRS. Pathway will include using the validated screening tool to identify ‘at-risk’
postpartum patients. Using Health Connect we will audit all perinatal patients charts to
ensure that all positive patients have a Social Work referral and are seen before
discharge. The obstetric provider will contact inpatient Psych MD when needed (for
moderate and high risk patients), and work with the primary RN to make sure the patient
gets resources handout prior to discharge.
A) Aim Statement:
To use established mental health screening to identify suicidal postpartum patients
and develop an inpatient clinical pathway that includes interventions and resources
to be shared with 90% of these patients by July of 2021.

B) Description of Intervention:
Create an easy-to-use pathway for nurses and providers when postpartum patients
screen positive on the C-SSRS. Have interventions and resources available for the
patients.
C) How will this intervention change practice?
Earlier and consistent detection of at-risk, or suicidal, patients provides additional
support and treatment. Up to date list of resources available for all postpartum
patients, consistently given to those who screen positive.
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D) Outcome measurements:
All patients that screen positive on the C-SSRS will be put on the C-SSRS
pathway.
Social Work referrals will be entered into HealthConnect (by the primary nurse)
when patients screen positive on the C-SSRS pathway.
Social Work and the Obstetrical provider determine which patients the inpatient
Psych MD needs to see (based off of guidelines to be determined).
All positive C-SSRS patients receive resource handout before discharge.
To qualify as an Evidence-based Change in Practice Project, rather than a Research Project, the
criteria outlined in federal guidelines will be used:
(http://answers.hhs.gov/ohrp/categories/1569)

☐ This project meets the guidelines for an Evidence-based Change in Practice Project as
outlined in the Project Checklist (attached). Student may proceed with implementation.

☐This project involves research with human subjects and must be submitted for IRB approval
before project activity can commence.
Comments:
EVIDENCE-BASED CHANGE OF PRACTICE PROJECT CHECKLIST *

Instructions: Answer YES or NO to each of the following statements:
Project Title: Columbia-Suicide Severity Rating Scale (C-SSRS) Inpatient
Perinatal Clinical Pathway
The aim of the project is to improve the process or delivery of care with
established/ accepted standards, or to implement evidence-based change. There is
no intention of using the data for research purposes.
The specific aim is to improve performance on a specific service or program and is
a part of usual care. ALL participants will receive standard of care.
The project is NOT designed to follow a research design, e.g., hypothesis testing
or group comparison, randomization, control groups, prospective comparison
groups, cross-sectional, case control). The project does NOT follow a protocol that
overrides clinical decision-making.
The project involves implementation of established and tested quality standards
and/or systematic monitoring, assessment or evaluation of the organization to
ensure that existing quality standards are being met. The project does NOT
develop paradigms or untested methods or new untested standards.

YES

X

X
X

X

NO
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The project involves implementation of care practices and interventions that are
consensus-based or evidence-based. The project does NOT seek to test an
intervention that is beyond current science and experience.
The project is conducted by staff where the project will take place and involves
staff who are working at an agency that has an agreement with USF SONHP.
The project has NO funding from federal agencies or research-focused
organizations and is not receiving funding for implementation research.
The agency or clinical practice unit agrees that this is a project that will be
implemented to improve the process or delivery of care, i.e., not a personal
research project that is dependent upon the voluntary participation of colleagues,
students and/ or patients.
If there is an intent to, or possibility of publishing your work, you and supervising
faculty and the agency oversight committee are comfortable with the following
statement in your methods section: “This project was undertaken as an Evidencebased change of practice project at X hospital or agency and as such was not
formally supervised by the Institutional Review Board.”

X

X
X
X

X

ANSWER KEY: If the answer to ALL of these items is yes, the project can be considered an
Evidence-based activity that does NOT meet the definition of research. IRB review is not
required. Keep a copy of this checklist in your files. If the answer to ANY of these questions
is NO, you must submit for IRB approval.
*Adapted with permission of Elizabeth L. Hohmann, MD, Director and Chair, Partners Human
Research Committee, Partners Health System, Boston, MA.

STUDENT NAME (Please print):
_____________________________Kristin Schoen______________
Signature of Student:
______________________________________________________DATE__4/7/2021___

SUPERVISING FACULTY MEMBER NAME (Please print):
________________________________________________________________________
Signature of Supervising Faculty Member
Liesel Buchner_DATE__4/11/2021_
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Appendix J. Outcomes Run Chart

